333 related articles for article (PubMed ID: 24724090)
1. Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.
Lin G; Chung YL
Biomed Res Int; 2014; 2014():625095. PubMed ID: 24724090
[TBL] [Abstract][Full Text] [Related]
2. Hyperpolarized 13C MRI and PET: in vivo tumor biochemistry.
Gallagher FA; Bohndiek SE; Kettunen MI; Lewis DY; Soloviev D; Brindle KM
J Nucl Med; 2011 Sep; 52(9):1333-6. PubMed ID: 21849405
[TBL] [Abstract][Full Text] [Related]
3. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
[TBL] [Abstract][Full Text] [Related]
4. Metabolic tumor imaging using magnetic resonance spectroscopy.
Glunde K; Bhujwalla ZM
Semin Oncol; 2011 Feb; 38(1):26-41. PubMed ID: 21362514
[TBL] [Abstract][Full Text] [Related]
5. Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.
Lin G; Keshari KR; Park JM
Contrast Media Mol Imaging; 2017; 2017():6053879. PubMed ID: 29114178
[TBL] [Abstract][Full Text] [Related]
6. Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.
Zaccagna F; Grist JT; Deen SS; Woitek R; Lechermann LM; McLean MA; Basu B; Gallagher FA
Br J Radiol; 2018 May; 91(1085):20170688. PubMed ID: 29293376
[TBL] [Abstract][Full Text] [Related]
7. Hyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs.
Lumata L; Yang C; Ragavan M; Carpenter N; DeBerardinis RJ; Merritt ME
Methods Enzymol; 2015; 561():73-106. PubMed ID: 26358902
[TBL] [Abstract][Full Text] [Related]
8. Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.
Keshari KR; Wilson DM; Van Criekinge M; Sriram R; Koelsch BL; Wang ZJ; VanBrocklin HF; Peehl DM; O'Brien T; Sampath D; Carano RA; Kurhanewicz J
Prostate; 2015 Oct; 75(14):1601-9. PubMed ID: 26177608
[TBL] [Abstract][Full Text] [Related]
9. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
10. Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.
Pantel AR; Ackerman D; Lee SC; Mankoff DA; Gade TP
J Nucl Med; 2018 Sep; 59(9):1340-1349. PubMed ID: 30042161
[TBL] [Abstract][Full Text] [Related]
11. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
12. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
Kim ES; Satter M; Reed M; Fadell R; Kardan A
Neuroradiol J; 2016 Jun; 29(3):193-7. PubMed ID: 27122050
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
Kim MM; Parolia A; Dunphy MP; Venneti S
Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.
Gutte H; Hansen AE; Larsen MM; Rahbek S; Henriksen ST; Johannesen HH; Ardenkjaer-Larsen J; Kristensen AT; Højgaard L; Kjær A
J Nucl Med; 2015 Nov; 56(11):1786-92. PubMed ID: 26338899
[TBL] [Abstract][Full Text] [Related]
15. [New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
Borbély K
Magy Onkol; 2015 Mar; 59(1):10-6. PubMed ID: 25763908
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography.
Cho N; Im SA; Kang KW; Park IA; Song IC; Lee KH; Kim TY; Lee H; Chun IK; Yoon HJ; Moon WK
Eur Radiol; 2016 Jul; 26(7):2279-90. PubMed ID: 26376886
[TBL] [Abstract][Full Text] [Related]
17. Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents.
Beloueche-Babari M; Workman P; Leach MO
Cell Cycle; 2011 Sep; 10(17):2883-93. PubMed ID: 21857160
[TBL] [Abstract][Full Text] [Related]
18. Oncologic imaging end-points for the assessment of therapy response.
Serkova NJ; Garg K; Bradshaw-Pierce EL
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
[TBL] [Abstract][Full Text] [Related]
19. Imaging and 'omic' methods for the molecular diagnosis of cancer.
Bohndiek SE; Brindle KM
Expert Rev Mol Diagn; 2010 May; 10(4):417-34. PubMed ID: 20465497
[TBL] [Abstract][Full Text] [Related]
20. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
Witney TH; Lewis DY
Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
